Follow
Samuel Benchimol
Samuel Benchimol
Professor, Department of Biology, York University
Verified email at yorku.ca
Title
Cited by
Cited by
Year
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
H Vaziri, S Benchimol
Current Biology 8 (5), 279-282, 1998
13491998
p53: oncogene or anti-oncogene
DP Lane, S Benchimol
Genes Dev 4 (1), 1-8, 1990
11721990
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng, Y Lin, W Ma, H Wu, B Lemmers, S Chung, JM Parant, G Lozano, ...
Cell 112 (6), 779-791, 2003
9542003
ATM‐dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post‐translational activation of p53 protein involving poly (ADP‐ribose) polymerase
H Vaziri, MD West, RC Allsopp, TS Davison, YS Wu, CH Arrowsmith, ...
The EMBO journal, 1997
5131997
Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis
Y Lin, W Ma, S Benchimol
Nature genetics 26 (1), 122-127, 2000
4872000
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
M Mowat, A Cheng, N Kimura, A Bernstein, S Benchimol
Nature 314 (6012), 633-636, 1985
4561985
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
H Ahuja, M Bar-Eli, SH Advani, S Benchimol, MJ Cline
Proceedings of the National Academy of Sciences 86 (17), 6783-6787, 1989
4041989
p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest
JSL Ho, W Ma, DYL Mao, S Benchimol
Molecular and cellular biology 25 (17), 7423-7431, 2005
3612005
p53-dependent pathways of apoptosis
S Benchimol
Cell death and differentiation 8 (11), 1049-1051, 2001
3012001
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
RG Bristow, S Benchimol, RP Hill
Radiotherapy and oncology 40 (3), 197-223, 1996
2951996
Transcriptional repression mediated by the p53 tumour suppressor.
J Ho, S Benchimol
Cell Death & Differentiation 10 (4), 2003
2802003
Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
VR Prideaux, V Chow, S Benchimol, A Bernstein
Oncogene 3 (2), 179-185, 1988
2251988
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
B Rovinski, S Benchimol
Oncogene 2 (5), 445-452, 1988
2111988
ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress
W Assaily, DA Rubinger, K Wheaton, Y Lin, W Ma, W Xuan, ...
Molecular cell 44 (3), 491-501, 2011
1962011
Expression of Wild-Type p53 Is Not Compatible with-Continued Growth of p53-Negative Tumor Cells
P Johnson, D Gray, M Mowat, S Benchimol
Molecular and cellular biology, 1991
1921991
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin
P Johnson, S Chung, S Benchimol
Molecular and Cellular Biology 13 (3), 1456-1463, 1993
1831993
The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
RL Zastawny, R Salvino, J Chen, S Benchimol, V Ling
Oncogene 8 (6), 1529-1535, 1993
1731993
Transformation associated p53 protein is encoded by a gene on human chromosome 17
S Benchimol, P Lamb, LV Crawford, D Sheer, TB Shows, GAP Bruns, ...
Somatic cell and molecular genetics 11, 505-510, 1985
1691985
Mutation of the p53 gene in human acute myelogenous leukemia
JM Slingerland, MD Minden, S Benchimol
1571991
Participation of the human p53 3′ UTR in translational repression and activation following γ‐irradiation
L Fu, S Benchimol
The EMBO journal, 1997
1521997
The system can't perform the operation now. Try again later.
Articles 1–20